相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disease area and mode of action as criteria to assign a default occupational exposure limit
Milica Glogovac et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
Kamila Gromek et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Considerations for setting occupational exposure limits for novel pharmaceutical modalities
Jessica C. Graham et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations
Janet C. Gould et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection
J. Stuart Elborn et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
Patrick A. Flume et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals
John F. Reichard et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs)
Joel P. Bercu et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry
Ester Lovsin Barle et al.
TOXICOLOGICAL SCIENCES (2016)
Managing the Risk of Occupational Allergy in the Enzyme Detergent Industry
David A. Basketter et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE (2015)
Historical Context and Recent Advances in Exposure-Response Estimation for Deriving Occupational Exposure Limits
M. W. Wheeler et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE (2015)
Advances in Inhalation Dosimetry Models and Methods for Occupational Risk Assessment and Exposure Limit Derivation
Eileen D. Kuempel et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE (2015)
The Scientific Basis of Uncertainty Factors Used in Setting Occupational Exposure Limits
D. A. Dankovic et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE (2015)
Development of levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
Chris Stockmann et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2014)
Bioavailability of Therapeutic Proteins by Inhalation-Worker Safety Aspects
Thomas Pfister et al.
ANNALS OF OCCUPATIONAL HYGIENE (2014)
Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products
Edward V. Sargent et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2013)
Dienogest A Review of its Use in the Treatment of Endometriosis
Paul L. McCormack
DRUGS (2010)
Investigations of the Use of Bioavailability Data to Adjust Occupational Exposure Limits for Active Pharmaceutical Ingredients
Bruce D. Naumann et al.
TOXICOLOGICAL SCIENCES (2009)
Background, approaches and recent trends for setting health-based occupational exposure limits: A minireview
Gunnar Damgard Nielsen et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development
GD Cappon et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2003)
Comparison of developmental toxicology of aspirin,(acetylsalicylic acid) in rats using selected dosing paradigms
U Gupta et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2003)
The importance of human data in the establishment of occupational exposure limits
EV Sargent et al.
HUMAN AND ECOLOGICAL RISK ASSESSMENT (2002)
A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections
SJ Martin et al.
DRUG SAFETY (2001)
分享论文
